A FUCOSE RESIDUE CAN MASK THE MUC-1 EPITOPES IN NORMAL AND CANCEROUS GASTRIC MUCOSAE

被引:40
作者
BARA, J
IMBERTY, A
PEREZ, S
IMAI, K
YACHI, A
ORIOL, R
机构
[1] UNIV SCI & TECH,CNRS,LSO,NANTES,FRANCE
[2] INSERM,U 178,F-94807 VILLEJUIF,FRANCE
[3] SAPPORO MED COLL,DEPT INTERNAL MED,CHUO KU,SAPPORO,HOKKAIDO 060,JAPAN
关键词
D O I
10.1002/ijc.2910540414
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MUSE11, DF3 and SM3 MAbs react with a synthetic peptide of 20 amino-acids: VTSAPDTRPAPGSTAPPAHG. This sequence is a tandem repeat domain of the mucin-type glycoprotein coded by the muc-1 gene. MUSE11 and DF3 MAbs immunoreact strongly with mucus cells of the normal surface gastric epithelium of Le(a+b-) non-secretors, but in spite of the peptidic nature of the recognized epitope, the same tissue of Le(a-b+) secretors reacts only after treatment with alpha-fucosidase. These reactions are inhibited by the PNA lectin, which recognizes the T disaccharide antigen (betaGal1-3alphaGalNAc), suggesting that the peptide epitope may be close to the T-saccharide structure. The SM3 MAb reacted on the surface gastric epithelium of all individuals after a more drastic deglycosylation using 20 mM periodate. Computer modeling of the MUC-1 immunoreactive glycopeptide containing the H type-3 trisaccharide alphaFuc1-2betaGal1-3alphaGalNAc- bound to the threonine of the PDTRP-pentapeptide shows that the peptide epitope might be masked when the fucose is positioned over the arginine. Thus, a single fucose linked to the T structure could mask the MUC-1 epitopes. In gastric adenocarcinomas, MUSE11 and SM3 epitopes are expressed in 75% (25/33) and 9% (3/33) respectively, while, after partial deglycosylation by periodate treatment, they are positive in 100% (33/33) and 70% (23/33) of cases, respectively. (C) 1993 Wiley-Liss, Inc.
引用
收藏
页码:607 / 613
页数:7
相关论文
共 19 条
  • [1] ABE M, 1989, CANCER RES, V49, P2834
  • [2] BAN T, 1989, CANCER RES, V49, P7141
  • [3] IMMUNOHISTOLOGICAL CHARACTERIZATION OF MUCIN EPITOPES BY PRETREATMENT OF GASTROINTESTINAL SECTIONS WITH PERIODIC ACID
    BARA, J
    DECAENS, C
    LORIDONROSA, B
    ORIOL, R
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1992, 149 (01) : 105 - 113
  • [4] A SHORT SEQUENCE, WITHIN THE AMINO-ACID TANDEM REPEAT OF A CANCER-ASSOCIATED MUCIN, CONTAINS IMMUNODOMINANT EPITOPES
    BURCHELL, J
    TAYLORPAPADIMITRIOU, J
    BOSHELL, M
    GENDLER, S
    DUHIG, T
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1989, 44 (04) : 691 - 696
  • [5] BURCHELL J, 1987, CANCER RES, V47, P5476
  • [6] VALIDATION OF THE GENERAL-PURPOSE TRIPOS 5.2 FORCE-FIELD
    CLARK, M
    CRAMER, RD
    VANOPDENBOSCH, N
    [J]. JOURNAL OF COMPUTATIONAL CHEMISTRY, 1989, 10 (08) : 982 - 1012
  • [7] MONTE-CARLO CALCULATIONS ON THE CONFORMATIONS OF MODELS FOR THE GLYCOPEPTIDE LINKAGE OF GLYCOPROTEINS
    DUBEN, AJ
    BUSH, CA
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1983, 225 (01) : 1 - 15
  • [8] GENDLER S, 1988, J BIOL CHEM, V263, P12820
  • [9] RECOGNITION OF THE POLYPEPTIDE CORE OF MUCIN BY MONOCLONAL-ANTIBODY MUSE11 AGAINST AN ADENOCARCINOMA-ASSOCIATED ANTIGEN
    HINODA, Y
    NAKAGAWA, N
    OHE, Y
    KAKIUCHI, H
    TSUJISAKI, M
    IMAI, K
    YACHI, A
    [J]. JAPANESE JOURNAL OF CANCER RESEARCH, 1990, 81 (12): : 1206 - 1209
  • [10] HULL SR, 1988, J CELL BIOCH SE, V12, P130